{"transactions":[{"id":811392,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":53070,"kind":"person","name":"Pavao Mark H","position":1,"cik":"0001297988","reported_name":"Pavao Mark H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-09T22:49:58.000Z","date":"2026-04-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":4.53,"expiration_date":"2036-04-09","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-149968","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297988/000119312526149968/ownership.xml","form_type":"4"}},{"id":930941,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68769,"kind":"person","name":"Grossman Fred","position":1,"cik":"0001985154","reported_name":"Grossman Fred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-26T13:00:06.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":140041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service through each vesting date, the shares underlying the option will vest in monthly installments over the next 36 months. Upon a change in control of the Issuer, the shares underlying the option will vest and the option will become immediately exercisable pursuant to the Issuer's 2021 Equity Incentive Plan, as amended and restated effective November 17, 2022."}],"balance_after":140041,"derivative":{"exercise_price":4.73,"expiration_date":"2036-01-22","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":140041},"source":{"system":"sec-edgar","filing":"0001193125-26-021728","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526021728/ownership.xml","form_type":"4"}},{"id":930940,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-26T13:00:04.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":15257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service through each vesting date, the shares underlying the option will vest in monthly installments over the next 36 months. Upon a change in control of the Issuer, the shares underlying the option will vest and the option will become immediately exercisable pursuant to the Issuer's 2021 Equity Incentive Plan, as amended and restated effective November 17, 2022."}],"balance_after":15257,"derivative":{"exercise_price":4.73,"expiration_date":"2036-01-22","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":15257},"source":{"system":"sec-edgar","filing":"0001193125-26-021725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526021725/ownership.xml","form_type":"4"}},{"id":931039,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68781,"kind":"person","name":"SNYDER DAVID S","position":1,"cik":"0001398625","reported_name":"SNYDER DAVID S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-26T08:00:07.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":140041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service through each vesting date, the shares underlying the option will vest in monthly installments over the next 36 months. Upon a change in control of the Issuer, the shares underlying the option will vest and the option will become immediately exercisable pursuant to the Issuer's 2021 Equity Incentive Plan, as amended and restated effective November 17, 2022."}],"balance_after":140041,"derivative":{"exercise_price":4.73,"expiration_date":"2036-01-22","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":140041},"source":{"system":"sec-edgar","filing":"0001193125-26-021729","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398625/000119312526021729/ownership.xml","form_type":"4"}},{"id":931295,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68805,"kind":"person","name":"Swaminathan Arun","position":1,"cik":"0002034346","reported_name":"Swaminathan Arun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-26T08:00:03.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":293983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service through each vesting date, the shares underlying the option will vest in monthly installments over the next 36 months. Upon a change in control of the Issuer, the shares underlying the option will vest and the option will become immediately exercisable pursuant to the Issuer's 2021 Equity Incentive Plan, as amended and restated effective November 17, 2022."}],"balance_after":293983,"derivative":{"exercise_price":4.73,"expiration_date":"2036-01-22","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":293983},"source":{"system":"sec-edgar","filing":"0001193125-26-021724","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034346/000119312526021724/ownership.xml","form_type":"4"}},{"id":945490,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69925,"kind":"person","name":"Villalobos Anabella","position":1,"cik":"0001952966","reported_name":"Villalobos Anabella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T00:27:14.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":5.65,"exercise_date":"2027-01-02","expiration_date":"2036-01-02","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-005024","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526005024/ownership.xml","form_type":"4"}},{"id":948258,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":29909,"kind":"person","name":"GOLDSTEIN DOV A MD","position":1,"cik":"0001120478","reported_name":"GOLDSTEIN DOV A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T00:27:10.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":5.65,"exercise_date":"2027-01-02","expiration_date":"2036-01-02","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-005023","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120478/000119312526005023/ownership.xml","form_type":"4"}},{"id":946861,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":53415,"kind":"person","name":"Weinand Dieter","position":1,"cik":"0001744419","reported_name":"Weinand Dieter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T00:26:44.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":5.65,"exercise_date":"2027-01-02","expiration_date":"2036-01-02","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-005022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744419/000119312526005022/ownership.xml","form_type":"4"}},{"id":945489,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T00:21:56.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":5.65,"exercise_date":"2027-01-02","expiration_date":"2036-01-02","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-005015","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526005015/ownership.xml","form_type":"4"}},{"id":947986,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":70104,"kind":"person","name":"ROSS WILBUR L JR","position":1,"cik":"0001026610","reported_name":"ROSS WILBUR L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T19:25:03.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":5.65,"exercise_date":"2027-01-02","expiration_date":"2036-01-02","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-005018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1026610/000119312526005018/ownership.xml","form_type":"4"}},{"id":1062810,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":29909,"kind":"person","name":"GOLDSTEIN DOV A MD","position":1,"cik":"0001120478","reported_name":"GOLDSTEIN DOV A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-19T20:01:23.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":17557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.09,"exercise_date":"2021-04-01","expiration_date":"2031-03-30","underlying":"Common Stock","underlying_shares":17557},"source":{"system":"sec-edgar","filing":"0001641172-25-024820","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1120478/000164117225024820/ownership.xml","form_type":"4"}},{"id":1062809,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":29909,"kind":"person","name":"GOLDSTEIN DOV A MD","position":1,"cik":"0001120478","reported_name":"GOLDSTEIN DOV A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-08-19T20:01:23.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":17557,"price":1.09,"value":19137.13,"ownership":{"direct":true},"balance_after":27557,"source":{"system":"sec-edgar","filing":"0001641172-25-024820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120478/000164117225024820/ownership.xml","form_type":"4"}},{"id":1245084,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-26T02:30:08.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.97,"expiration_date":"2035-02-25","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-027255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017025027255/ownership.xml","form_type":"4"}},{"id":1245082,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69925,"kind":"person","name":"Villalobos Anabella","position":1,"cik":"0001952966","reported_name":"Villalobos Anabella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-26T02:30:07.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.97,"expiration_date":"2035-02-25","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-027254","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017025027254/ownership.xml","form_type":"4"}},{"id":1247495,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":29909,"kind":"person","name":"GOLDSTEIN DOV A MD","position":1,"cik":"0001120478","reported_name":"GOLDSTEIN DOV A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-26T02:30:05.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.97,"expiration_date":"2035-02-25","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-027253","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120478/000095017025027253/ownership.xml","form_type":"4"}},{"id":1246357,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":53415,"kind":"person","name":"Weinand Dieter","position":1,"cik":"0001744419","reported_name":"Weinand Dieter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-26T02:30:04.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.97,"expiration_date":"2035-02-25","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-027252","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744419/000095017025027252/ownership.xml","form_type":"4"}},{"id":1247382,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":70104,"kind":"person","name":"ROSS WILBUR L JR","position":1,"cik":"0001026610","reported_name":"ROSS WILBUR L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-25T21:30:03.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.97,"expiration_date":"2035-02-25","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-027251","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1026610/000095017025027251/ownership.xml","form_type":"4"}},{"id":1304103,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68769,"kind":"person","name":"Grossman Fred","position":1,"cik":"0001985154","reported_name":"Grossman Fred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-13T13:00:05.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":140562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date."}],"balance_after":140562,"derivative":{"exercise_price":6.07,"expiration_date":"2035-01-09","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":140562},"source":{"system":"sec-edgar","filing":"0000950170-25-004572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017025004572/ownership.xml","form_type":"4"}},{"id":1304102,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-13T13:00:03.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":150602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date."}],"balance_after":150602,"derivative":{"exercise_price":6.07,"expiration_date":"2035-01-09","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":150602},"source":{"system":"sec-edgar","filing":"0000950170-25-004571","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017025004571/ownership.xml","form_type":"4"}},{"id":1304166,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68781,"kind":"person","name":"SNYDER DAVID S","position":1,"cik":"0001398625","reported_name":"SNYDER DAVID S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-13T08:00:07.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":140562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date."}],"balance_after":140562,"derivative":{"exercise_price":6.07,"expiration_date":"2035-01-09","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":140562},"source":{"system":"sec-edgar","filing":"0000950170-25-004575","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398625/000095017025004575/ownership.xml","form_type":"4"}},{"id":1304472,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68805,"kind":"person","name":"Swaminathan Arun","position":1,"cik":"0002034346","reported_name":"Swaminathan Arun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-13T08:00:06.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":240964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date."}],"balance_after":240964,"derivative":{"exercise_price":6.07,"expiration_date":"2035-01-09","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":240964},"source":{"system":"sec-edgar","filing":"0000950170-25-004573","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034346/000095017025004573/ownership.xml","form_type":"4"}},{"id":1316423,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":29909,"kind":"person","name":"GOLDSTEIN DOV A MD","position":1,"cik":"0001120478","reported_name":"GOLDSTEIN DOV A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-04T02:31:12.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.73,"exercise_date":"2026-01-01","expiration_date":"2035-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-001571","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120478/000095017025001571/ownership.xml","form_type":"4"}},{"id":1313151,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-04T02:30:21.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.73,"exercise_date":"2026-01-01","expiration_date":"2035-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-001569","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017025001569/ownership.xml","form_type":"4"}},{"id":1313149,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69925,"kind":"person","name":"Villalobos Anabella","position":1,"cik":"0001952966","reported_name":"Villalobos Anabella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-04T02:30:20.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.73,"exercise_date":"2026-01-01","expiration_date":"2035-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-001568","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017025001568/ownership.xml","form_type":"4"}},{"id":1314957,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":53415,"kind":"person","name":"Weinand Dieter","position":1,"cik":"0001744419","reported_name":"Weinand Dieter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-04T02:30:18.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.73,"exercise_date":"2026-01-01","expiration_date":"2035-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-001567","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744419/000095017025001567/ownership.xml","form_type":"4"}},{"id":1316273,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":70104,"kind":"person","name":"ROSS WILBUR L JR","position":1,"cik":"0001026610","reported_name":"ROSS WILBUR L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T21:30:37.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.73,"exercise_date":"2026-01-01","expiration_date":"2035-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-001570","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1026610/000095017025001570/ownership.xml","form_type":"4"}},{"id":1364825,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68781,"kind":"person","name":"SNYDER DAVID S","position":1,"cik":"0001398625","reported_name":"SNYDER DAVID S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-11-14T18:08:32.000Z","date":"2024-11-14","kind":"purchase","planned":false,"acquired":true,"shares":1800,"price":7.1858,"value":12934.44,"ownership":{"direct":true},"balance_after":8800,"source":{"system":"sec-edgar","filing":"0001493152-24-046106","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398625/000149315224046106/ownership.xml","form_type":"4"}},{"id":1366897,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68805,"kind":"person","name":"Swaminathan Arun","position":1,"cik":"0002034346","reported_name":"Swaminathan Arun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-11-13T16:05:16.000Z","date":"2024-11-13","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":7.3594,"value":36797.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-24-045120","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034346/000149315224045120/ownership.xml","form_type":"4"}},{"id":1368015,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68769,"kind":"person","name":"Grossman Fred","position":1,"cik":"0001985154","reported_name":"Grossman Fred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-11-12T23:03:34.000Z","date":"2024-11-11","kind":"purchase","planned":false,"acquired":true,"shares":2710,"price":7.37,"value":19972.7,"ownership":{"direct":true},"balance_after":2710,"source":{"system":"sec-edgar","filing":"0001493152-24-044896","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315224044896/ownership.xml","form_type":"4"}},{"id":1369330,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68805,"kind":"person","name":"Swaminathan Arun","position":1,"cik":"0002034346","reported_name":"Swaminathan Arun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-11-12T16:58:37.000Z","date":"2024-11-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":7.3378,"value":36689.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001493152-24-044819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034346/000149315224044819/ownership.xml","form_type":"4"}},{"id":1489332,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-06T00:00:04.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":163663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months, commencing on July 3, 2024."}],"balance_after":163663,"derivative":{"exercise_price":8.15,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":163663},"source":{"system":"sec-edgar","filing":"0000950170-24-069550","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017024069550/ownership.xml","form_type":"4"}},{"id":1489331,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68769,"kind":"person","name":"Grossman Fred","position":1,"cik":"0001985154","reported_name":"Grossman Fred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-06T00:00:03.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":70596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months, commencing on July 3, 2024."}],"balance_after":70596,"derivative":{"exercise_price":8.15,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":70596},"source":{"system":"sec-edgar","filing":"0000950170-24-069549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017024069549/ownership.xml","form_type":"4"}},{"id":1489610,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68781,"kind":"person","name":"SNYDER DAVID S","position":1,"cik":"0001398625","reported_name":"SNYDER DAVID S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-05T20:00:06.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":70596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months, commencing on July 3, 2024."}],"balance_after":70596,"derivative":{"exercise_price":8.15,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":70596},"source":{"system":"sec-edgar","filing":"0000950170-24-069551","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398625/000095017024069551/ownership.xml","form_type":"4"}},{"id":1593413,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-03-06T01:00:30.000Z","date":"2023-08-22","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":3.62,"value":3620.0,"ownership":{"direct":false,"nature":"By Spouse IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. The actual purchase prices range from $3.59 to $3.63 per share. The Reporting Person will supply the SEC, the Issuer, or a security holder of the Issuer, with full information regarding the number of shares at each price upon request."}],"balance_after":17479,"source":{"system":"sec-edgar","filing":"0001493152-24-008916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315224008916/ownership.xml","form_type":"4"}},{"id":1660524,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68769,"kind":"person","name":"Grossman Fred","position":1,"cik":"0001985154","reported_name":"Grossman Fred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-03T01:00:19.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":74069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest as to 24,689 shares on July 11, 2024, with the remaining shares vesting in 24 equal monthly installments."}],"balance_after":74069,"derivative":{"exercise_price":5.9,"expiration_date":"2034-01-31","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":74069},"source":{"system":"sec-edgar","filing":"0001493152-24-004813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315224004813/ownership.xml","form_type":"4"}},{"id":1660523,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68769,"kind":"person","name":"Grossman Fred","position":1,"cik":"0001985154","reported_name":"Grossman Fred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-03T01:00:19.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":81819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date."}],"balance_after":81819,"derivative":{"exercise_price":5.9,"expiration_date":"2034-01-31","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":81819},"source":{"system":"sec-edgar","filing":"0001493152-24-004813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315224004813/ownership.xml","form_type":"4"}},{"id":1660522,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-03T01:00:12.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":189680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date."}],"balance_after":189680,"derivative":{"exercise_price":5.9,"expiration_date":"2034-01-31","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":189680},"source":{"system":"sec-edgar","filing":"0001493152-24-004814","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315224004814/ownership.xml","form_type":"4"}},{"id":1661013,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68781,"kind":"person","name":"SNYDER DAVID S","position":1,"cik":"0001398625","reported_name":"SNYDER DAVID S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-02T20:00:15.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":81819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date."}],"balance_after":81819,"derivative":{"exercise_price":5.9,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":81819},"source":{"system":"sec-edgar","filing":"0001493152-24-004815","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398625/000149315224004815/ownership.xml","form_type":"4"}},{"id":1675293,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":53415,"kind":"person","name":"Weinand Dieter","position":1,"cik":"0001744419","reported_name":"Weinand Dieter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-19T23:30:35.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":7.41,"exercise_date":"2025-01-01","expiration_date":"2034-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-24-003109","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744419/000149315224003109/ownership.xml","form_type":"4"}},{"id":1675768,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":29909,"kind":"person","name":"GOLDSTEIN DOV A MD","position":1,"cik":"0001120478","reported_name":"GOLDSTEIN DOV A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-19T23:30:28.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":7.41,"exercise_date":"2025-01-01","expiration_date":"2034-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-24-003110","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120478/000149315224003110/ownership.xml","form_type":"4"}},{"id":1674903,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-19T23:30:22.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":7.41,"exercise_date":"2025-01-01","expiration_date":"2034-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-24-003108","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315224003108/ownership.xml","form_type":"4"}},{"id":1674902,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69925,"kind":"person","name":"Villalobos Anabella","position":1,"cik":"0001952966","reported_name":"Villalobos Anabella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-19T23:30:16.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":7.41,"exercise_date":"2025-01-01","expiration_date":"2034-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-24-003107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315224003107/ownership.xml","form_type":"4"}},{"id":1675387,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-19T18:30:33.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":7.41,"exercise_date":"2025-01-01","expiration_date":"2034-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-24-003111","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000149315224003111/ownership.xml","form_type":"4"}},{"id":1688801,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":70104,"kind":"person","name":"ROSS WILBUR L JR","position":1,"cik":"0001026610","reported_name":"ROSS WILBUR L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T16:05:46.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of appointment."}],"balance_after":10000,"derivative":{"exercise_price":6.97,"exercise_date":"2024-12-19","expiration_date":"2034-01-02","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-24-001080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1026610/000149315224001080/ownership.xml","form_type":"4"}},{"id":1800837,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":53415,"kind":"person","name":"Weinand Dieter","position":1,"cik":"0001744419","reported_name":"Weinand Dieter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-22T00:15:06.000Z","date":"2023-08-18","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":3.43,"exercise_date":"2024-08-18","expiration_date":"2033-08-18","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-23-018335","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744419/000089924323018335/doc4.xml","form_type":"4"}},{"id":1826563,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68769,"kind":"person","name":"Grossman Fred","position":1,"cik":"0001985154","reported_name":"Grossman Fred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-20T01:05:05.000Z","date":"2023-07-17","kind":"grant","planned":false,"acquired":true,"shares":74069,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Subject to continuous service, 24,689 of the shares subject to the option will vest on July 17, 2024, and the remaining shares will vest in equal monthly installments over a period of 24 months commencing on August 17, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 24,689 of the shares subject to the option will vest on July 17, 2024, and the remaining shares will vest in equal monthly installments over a period of 24 months commencing on August 17, 2024."}],"balance_after":74069,"derivative":{"exercise_price":4.25,"expiration_date":"2033-07-17","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":74069},"source":{"system":"sec-edgar","filing":"0001493152-23-024969","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223024969/ownership.xml","form_type":"4"}},{"id":1982799,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-01T21:05:30.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months commencing on March 27, 2023."}],"balance_after":165000,"derivative":{"exercise_price":3.85,"expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001493152-23-006392","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223006392/ownership.xml","form_type":"4"}},{"id":1983624,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-01T16:05:22.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months commencing on March 27, 2023."}],"balance_after":115000,"derivative":{"exercise_price":3.85,"expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001493152-23-006390","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1637347/000149315223006390/ownership.xml","form_type":"4"}},{"id":1983136,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68781,"kind":"person","name":"SNYDER DAVID S","position":1,"cik":"0001398625","reported_name":"SNYDER DAVID S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-01T16:05:17.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months commencing on March 27, 2023."}],"balance_after":115000,"derivative":{"exercise_price":3.85,"expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001493152-23-006389","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398625/000149315223006389/ownership.xml","form_type":"4"}},{"id":2065263,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-01-04T13:30:32.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":5000,"derivative":{"exercise_price":7.5,"exercise_date":"2023-01-03","expiration_date":"2025-01-03","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-23-000227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000227/ownership.xml","form_type":"4"}},{"id":2065262,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T13:30:32.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-23-000227","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000227/ownership.xml","form_type":"4"}},{"id":2065267,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"6% Convertible Note","published_at":"2023-01-04T13:30:27.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"price":0,"reported_value":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon the closing of the Issuer's IPO, the Convertible Note automatically converted into shares of common stock by dividing the then-outstanding principal and interest due under the Convertible Note by $4.00, or 80% of the IPO price. The Reporting Person held a Convertible Note for $25,000 that accrued interest at 6% per annum."},{"field":"reported_value","element":"transactionTotalValue","label":"F2","text":"Upon the closing of the Issuer's IPO, the Convertible Note automatically converted into shares of common stock by dividing the then-outstanding principal and interest due under the Convertible Note by $4.00, or 80% of the IPO price. The Reporting Person held a Convertible Note for $25,000 that accrued interest at 6% per annum."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the closing of the Issuer's IPO, the Convertible Note automatically converted into shares of common stock by dividing the then-outstanding principal and interest due under the Convertible Note by $4.00, or 80% of the IPO price. The Reporting Person held a Convertible Note for $25,000 that accrued interest at 6% per annum."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon the closing of the Issuer's IPO, the Convertible Note automatically converted into shares of common stock by dividing the then-outstanding principal and interest due under the Convertible Note by $4.00, or 80% of the IPO price. The Reporting Person held a Convertible Note for $25,000 that accrued interest at 6% per annum."}],"balance_after":6479,"derivative":{"exercise_price":4,"underlying":"Common Stock, par value $0.0001 per share","underlying_shares":6479},"source":{"system":"sec-edgar","filing":"0001493152-23-000226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000226/ownership.xml","form_type":"4"}},{"id":2065266,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-01-04T13:30:27.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering (\"IPO\") at a combined purchase price $5.00 per share and accompanying warrant."}],"balance_after":9479,"derivative":{"exercise_price":7.5,"exercise_date":"2023-01-03","expiration_date":"2025-01-03","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-23-000226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000226/ownership.xml","form_type":"4"}},{"id":2065265,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T13:30:27.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":6479,"price":4,"value":25916.0,"ownership":{"direct":true},"balance_after":16479,"source":{"system":"sec-edgar","filing":"0001493152-23-000226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000226/ownership.xml","form_type":"4"}},{"id":2065264,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T13:30:27.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering (\"IPO\") at a combined purchase price $5.00 per share and accompanying warrant."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-23-000226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000226/ownership.xml","form_type":"4"}},{"id":2069633,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":29909,"kind":"person","name":"GOLDSTEIN DOV A MD","position":1,"cik":"0001120478","reported_name":"GOLDSTEIN DOV A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-01-04T13:30:17.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":5000,"derivative":{"exercise_price":7.5,"exercise_date":"2023-01-03","expiration_date":"2025-01-03","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-23-000221","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1120478/000149315223000221/ownership.xml","form_type":"4"}},{"id":2069632,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":29909,"kind":"person","name":"GOLDSTEIN DOV A MD","position":1,"cik":"0001120478","reported_name":"GOLDSTEIN DOV A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T13:30:17.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-23-000221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120478/000149315223000221/ownership.xml","form_type":"4"}},{"id":2065261,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69925,"kind":"person","name":"Villalobos Anabella","position":1,"cik":"0001952966","reported_name":"Villalobos Anabella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-01-04T13:30:17.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":5000,"derivative":{"exercise_price":7.5,"exercise_date":"2023-01-03","expiration_date":"2025-01-03","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-23-000222","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000222/ownership.xml","form_type":"4"}},{"id":2065260,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69925,"kind":"person","name":"Villalobos Anabella","position":1,"cik":"0001952966","reported_name":"Villalobos Anabella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T13:30:17.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-23-000222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000222/ownership.xml","form_type":"4"}},{"id":2067609,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-01-04T08:30:25.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":5000,"derivative":{"exercise_price":7.5,"exercise_date":"2023-01-03","expiration_date":"2025-01-03","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-23-000225","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1637347/000149315223000225/ownership.xml","form_type":"4"}},{"id":2067608,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T08:30:25.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-23-000225","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1637347/000149315223000225/ownership.xml","form_type":"4"}},{"id":2068441,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-01-04T08:30:22.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 2,000 shares of Common Stock and an accompanying warrant to purchase 1,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":1000,"derivative":{"exercise_price":7.5,"exercise_date":"2023-01-03","expiration_date":"2025-01-03","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001493152-23-000223","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000149315223000223/ownership.xml","form_type":"4"}},{"id":2068440,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T08:30:22.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 2,000 shares of Common Stock and an accompanying warrant to purchase 1,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001493152-23-000223","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000149315223000223/ownership.xml","form_type":"4"}},{"id":2066095,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68781,"kind":"person","name":"SNYDER DAVID S","position":1,"cik":"0001398625","reported_name":"SNYDER DAVID S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-01-04T08:30:19.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":3500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 7,000 shares of Common Stock and an accompanying warrant to purchase 3,500 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":3500,"derivative":{"exercise_price":7.5,"exercise_date":"2023-01-03","expiration_date":"2025-01-03","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001493152-23-000224","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398625/000149315223000224/ownership.xml","form_type":"4"}},{"id":2066094,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":68781,"kind":"person","name":"SNYDER DAVID S","position":1,"cik":"0001398625","reported_name":"SNYDER DAVID S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T08:30:19.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 7,000 shares of Common Stock and an accompanying warrant to purchase 3,500 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001493152-23-000224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398625/000149315223000224/ownership.xml","form_type":"4"}}]}